Literature DB >> 31320248

Low serum choline and high serum betaine levels are associated with favorable components of metabolic syndrome in Newfoundland population.

Xiang Gao1, Edward Randell2, Yuan Tian3, Haicheng Zhou4, Guang Sun5.   

Abstract

BACKGROUND: We investigated the relationships between serum choline and betaine levels with metabolic syndrome-related indices in the general population of Newfoundland.
METHODS: 1081 adults were selected from the CODING study. Serum choline and betaine levels were measured. Major confounding factors were controlled in all analyses.
RESULTS: Partial correlation and linear regression analysis showed that serum choline levels were positively associated with systolic blood pressure (r: 0.124), serum TG levels (r: 0.132) and negatively correlated with serum glucose levels (r: -0.121) in males (p < 0.01 for all). In females, serum choline levels were positively correlated with serum TG, TC and HDL levels (r: 0.104 to 0.148, p < 0.05 for all). Serum betaine levels were negatively associated with serum TG, TC, LDL and insulin levels, and with atherogenic index and HOMA-IR index in males (r: -0.081 to -0.179, p < 0.05 for all). In females, serum betaine levels were negatively associated with serum TG, hsCRP and insulin levels, and with HOMA-IR index (r: -0.092 to -0.213, p < 0.05 for all). Moreover, subjects with serum choline levels in the highest tertile showed highest serum TG levels and systolic blood pressure in males, and highest serum lipids levels in females. Subjects with the highest serum betaine levels had the lowest serum lipids levels, atherogenic index, IR severity in males, and the lowest serum TG and hsCRP levels, and IR severity in females.
CONCLUSION: Low serum choline and high serum betaine levels are associated with favorable components of metabolic syndrome in general adults.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Betaine; Choline; Cross-sectional; Metabolic syndrome; Newfoundland

Mesh:

Substances:

Year:  2019        PMID: 31320248     DOI: 10.1016/j.jdiacomp.2019.06.003

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  5 in total

1.  Changes in Plasma Choline and the Betaine-to-Choline Ratio in Response to 6-Month Lifestyle Intervention Are Associated with the Changes of Lipid Profiles and Intestinal Microbiota: The ICAAN Study.

Authors:  HanByul Jang; Hyunjung Lim; Kyung-Hee Park; SangIck Park; Hye-Ja Lee
Journal:  Nutrients       Date:  2021-11-10       Impact factor: 5.717

2.  Restricting Branched-Chain Amino Acids within a High-Fat Diet Prevents Obesity.

Authors:  Ming Liu; Yiheng Huang; Hongwei Zhang; Dawn Aitken; Michael C Nevitt; Jason S Rockel; Jean-Pierre Pelletier; Cora E Lewis; James Torner; Yoga Raja Rampersaud; Anthony V Perruccio; Nizar N Mahomed; Andrew Furey; Edward W Randell; Proton Rahman; Guang Sun; Johanne Martel-Pelletier; Mohit Kapoor; Graeme Jones; David Felson; Dake Qi; Guangju Zhai
Journal:  Metabolites       Date:  2022-04-07

Review 3.  Detection of Early Disease Risk Factors Associated with Metabolic Syndrome: A New Era with the NMR Metabolomics Assessment.

Authors:  Julia Hernandez-Baixauli; Sergio Quesada-Vázquez; Roger Mariné-Casadó; Katherine Gil Cardoso; Antoni Caimari; Josep M Del Bas; Xavier Escoté; Laura Baselga-Escudero
Journal:  Nutrients       Date:  2020-03-18       Impact factor: 5.717

4.  Serum metabolomics in chickens infected with Cryptosporidium baileyi.

Authors:  Xue-Mei Wu; Xin Yang; Xian-Cheng Fan; Xi Chen; Yu-Xin Wang; Long-Xian Zhang; Jun-Ke Song; Guang-Hui Zhao
Journal:  Parasit Vectors       Date:  2021-06-26       Impact factor: 3.876

5.  Associations between Serum Betaine, Methyl-Metabolizing Genetic Polymorphisms and Risk of Incident Type 2 Diabetes: A Prospective Cohort Study in Community-Dwelling Chinese Adults.

Authors:  Xiaoting Lu; Rongzhu Huang; Shuyi Li; Aiping Fang; Yuming Chen; Si Chen; Fan Wang; Xinlei Lin; Zhaoyan Liu; Huilian Zhu
Journal:  Nutrients       Date:  2022-01-15       Impact factor: 5.717

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.